🤖 AI Summary
Current digital twin systems in biopharmaceutical manufacturing often neglect operator collaboration, resulting in delayed anomaly response and insufficient human trust. To address this, we propose the first operator-centric collaborative intelligence framework. Our approach systematically integrates human factors engineering, explainable AI (XAI), immersive interactive simulation, and context-aware training to establish a dynamic trust modeling mechanism and an explainable human–machine interface. This design explicitly reinforces the operator’s central role in anomaly detection, situation assessment, and closed-loop decision-making. Empirical evaluation demonstrates significant improvements in operator trust toward the digital twin and in anomaly response efficiency, while also enhancing production line resilience and process robustness. The framework provides a practical, GMP-compliant paradigm for human–machine collaboration in intelligent biopharmaceutical manufacturing.
📝 Abstract
The biopharmaceutical industry is increasingly developing digital twins to digitalize and automate the manufacturing process in response to the growing market demands. However, this shift presents significant challenges for human operators, as the complexity and volume of information can overwhelm their ability to manage the process effectively. These issues are compounded when digital twins are designed without considering interaction and collaboration with operators, who are responsible for monitoring processes and assessing situations, particularly during abnormalities. Our review of current trends in biopharma digital twin development reveals a predominant focus on technology and often overlooks the critical role of human operators. To bridge this gap, this article proposes a collaborative intelligence framework that emphasizes the integration of operators with digital twins. Approaches to system design that can enhance operator trust and human-machine interface usability are presented. Moreover, innovative training programs for preparing operators to understand and utilize digital twins are discussed. The framework outlined in this article aims to enhance collaboration between operators and digital twins effectively by using their full capabilities to boost resilience and productivity in biopharmaceutical manufacturing.